Eye-Tracking gadget aims to clear confusion in ICU patients

NCT ID NCT06029244

Completed Symptom relief Sponsor: Beth Israel Deaconess Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a wearable eye-tracking device called EyeControl-Pro in 160 older, ventilated ICU patients. The device lets patients communicate by moving their eyes, which may help reduce delirium—a state of confusion common in intensive care. Researchers compared patients who used the device to those who did not, checking for delirium over the first week.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: EyeControl-Pro wearable eye-tracking device
What this could lead to: If it works, this device could help reduce confusion and distress in ICU patients who cannot speak, improving their recovery.
What could go wrong: This is a small, completed trial with 160 patients. The device may not significantly reduce delirium, and results may not apply to all ICU settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Critical Illness delirium

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CRITICAL ILLNESS DELIRIUM DELIRIUM IN OLD AGE INTENSIVE CARE UNIT DELIRIUM

Contacts and locations

Locations

Assuta Ashdod Medical Center

Ashdod, Israel
Beth Israel Deaconess Medical Center

Boston, Massachusetts, 02215, United States
Rabin Medical Center

Petah Tikva, Israel

More trials for these conditions

Other studies related to the condition(s) this trial covers.